Pedro J. Beltran, PhD
Chief Scientific Officer
Pedro joined BridgeBio Pharma in 2020 as Senior Vice President of Biology and became Chief Scientific Officer of BBOT in July 2023. Prior to BridgeBio, Pedro was Senior Vice President, Head of Biology at UNITY Biotechnology and Executive Director, Oncology Research at Amgen, Inc. Pedro has led multiple IND filings, authored more than 50 peer-reviewed articles, presented at multiple national/international scientific conferences, and holds diverse patents for the treatment of malignant diseases.
Pedro completed postdoctoral work in Molecular and Cellular Pharmacology at the University of Miami, holds a PhD in Cancer Biology from the University of Texas, MD Anderson Cancer Center, and a BS in Molecular Biology from Florida Institute of Technology.